Oprah Winfrey's Change of Heart: Ozempic Users Praised by WeightWatchers

Oprah Winfrey is retracting her criticism of Ozempic users after endorsing the use of drugs like Ozempic to treat obesity. Winfrey, who once owned a 10% stake in WeightWatchers, bought shares of the company after her endorsement. In March, WeightWatchers acquired Sequence, a tele-health subscription service that prescribes Ozempic and other weight-loss drugs. Winfrey's initial comments caused WeightWatchers stock to plummet. She clarified that her comments were misconstrued and expressed support for prescription medications as an option for weight and health-related issues. WeightWatchers' pivot to promoting Ozempic is a change in strategy, as the company previously acknowledged its role in "shaming" customers for their weight. The popularity of Ozempic and similar drugs has led to increased profits for pharmaceutical companies but has also affected stocks, with Walmart reporting reduced grocery sales due to the medications.